SCHEMBL11029114

SCHEMBL11029114

Cc1ccc(C2CC(C)(C)c3cc(F)cc(C(N)=O)c3N2)cc1N1CCCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ YWHAG P61981 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ HTT P42858 1/20 0.35
▸ PARP1 P09874 3/20 0.34
▸ AR P10275 3/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ JAK1 P23458 1/20 0.32
▸ ADAMTS5 Q9UNA0 4/20 0.32
▸ MMP2 P08253 1/20 0.32
▸ JAK2 O60674 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11025566 0.89 MEN1 (0.37) MAPTKDM4EMEN1THRBALOX15
SCHEMBL11026178 0.86 HTR7 (0.34) MAPTARLMNA
SCHEMBL11029142 0.84 PARP1 (0.35) KDM4EMEN1KMT2AHSD17B10PARP1
SCHEMBL11029096 0.83 CDC7 (0.35) MAPTKDM4EMEN1THRBALOX15
SCHEMBL11026768 0.83 RPS6KB1 (0.35) MAPTMEN1KMT2APARP1AR
SCHEMBL11021415 0.78 MEN1 (0.39) MAPTKDM4EMEN1THRBKMT2A
SCHEMBL11025301 0.76 KDM4E (0.39) MAPTKDM4EMEN1GFERKMT2A
SCHEMBL11028093 0.75 PARP1 (0.32) PARP1GAA
SCHEMBL11023712 0.74 AR (0.37) MAPTKDM4EMEN1KMT2AAR
SCHEMBL11025564 0.74 CDC7 (0.35) MAPTKDM4EMEN1THRBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809369-B2 Tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2014-08-19 — — US claimed
US-20120190677-A1 NOVEL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — US claimed
US-8809369-B2 Tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2014-08-19 — — US disclosed
US-20120190677-A1 NOVEL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190677-A1 NOVEL TETRAHYDROQUINOLINE DERIVATIVES RAB1A, RABL3, RAB7A MAPT 3428/4885KDM4E 1324/4885MEN1 487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback